Short Interest in Coloplast A/S (OTCMKTS:CLPBY) Grows By 26.9%

Coloplast A/S (OTCMKTS:CLPBY) saw a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 77,000 shares, a growth of 26.9% from the February 13th total of 60,700 shares. Based on an average daily trading volume, of 268,300 shares, the days-to-cover ratio is presently 0.3 days.

Coloplast A/S Trading Up 0.8 %

Shares of OTCMKTS:CLPBY opened at $10.62 on Tuesday. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.02 and a quick ratio of 0.66. The stock has a 50 day moving average price of $11.06 and a 200-day moving average price of $12.08. Coloplast A/S has a 52-week low of $10.43 and a 52-week high of $14.14.

Coloplast A/S (OTCMKTS:CLPBY) last announced its earnings results on Tuesday, February 4th. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.01). Coloplast A/S had a net margin of 17.81% and a return on equity of 28.60%. On average, equities research analysts forecast that Coloplast A/S will post 0.31 EPS for the current year.

Wall Street Analysts Forecast Growth

CLPBY has been the topic of a number of recent analyst reports. Sanford C. Bernstein raised shares of Coloplast A/S from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 28th. Hsbc Global Res raised Coloplast A/S from a “moderate sell” rating to a “hold” rating in a research note on Monday, November 18th. Royal Bank of Canada raised Coloplast A/S from a “hold” rating to a “moderate buy” rating in a research report on Monday, March 3rd. Finally, UBS Group raised Coloplast A/S from a “strong sell” rating to a “hold” rating in a research note on Wednesday, December 11th.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.